6.6% and 3.9% yields! 2 FTSE 100 stocks I’d snap up for juicy returns

On the hunt for consistent and growing dividends, our writer earmarks these two FTSE 100 stalwarts that could help her achieve that.

| More on:
Young black colleagues high-fiving each other at work

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Two rock-solid FTSE 100 stocks I believe can offer good returns for me and my holdings are GSK (LSE: GSK) and Taylor Wimpey (LSE: TW.).

Here’s why I’d love to buy some shares when I next have some cash to invest.

GSK

As one of the leading names in pharmaceuticals, GSK offers excellent defensive traits, in my view. This is due to the cutting-edge pharma it produces with medicines and treatments to help the world heal from various ailments.

Last month, a judge in Delaware voted in favour of over 70,000 lawsuits to go ahead against the company. This related to GSK’s Zantac drug and its potential links to causing cancer. Although GSK denies any evidence to suggest a risk of cancer, the chance of major fines and reputational damage is a risk I’ll keep an eye on.

From a bullish view, and given the defensive aspects mentioned, I think there’s a lot to like about the business.

To start with, the shares currently trade on a price-to-earnings ratio of 14. It’s also set to go lower, based on forecasts. However, I do understand that forecasts don’t always come to fruition.

Next, GSK shares offer a dividend yield of 3.9%, which is broadly in line with the FTSE 100 average. I can see this dividend growing in the future too, based on the firm’s reputation, experience, and future pipeline. It is worth mentioning that dividends are never guaranteed.

Overall, an established name in the market, an enticing valuation, passive income opportunity, and what looks like a solid R&D pipeline with over 90 products to come, help me make an investment decision today.

Taylor Wimpey

House builders haven’t had a great time of things in the past 12-18 months, due to economic volatility. Higher inflation, interest rates, and a cost-of-living crisis have hurt earnings and sentiment.

Inflation levels are now down, and rumours of a potential interest rate cut could spell good news. A potential housing boom could be on the horizon. However, economic issues are one of the biggest risks for Taylor Wimpey, and something that could dent earnings and returns. For example, higher costs could mean tighter margins and profit levels. I’ll keep an eye on this.

If a housing boom is coming, Taylor Wimpey is primed to benefit. At present, the shares look attractive to me.

Taylor is one of the largest developers in the UK. It possesses a wide presence, as well as plenty of experience and a solid track record. This could serve it well as there is a housing crisis in the UK. With demand outstripping supply, there is an opportunity for the firm to capitalise, and grow earnings and performance.

Finally, the fundamentals look good to me too. Taylor possesses a healthy balance sheet, which can help stave off economic turbulence, as well as support growth. Plus, the shares offer a dividend yield of 6.6% and trade on a P/E ratio of just 14.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Sumayya Mansoor has no position in any of the shares mentioned. The Motley Fool UK has recommended GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Group of young friends toasting each other with beers in a pub
Investing Articles

How I’d try and turn a small SIPP into a £500k pension pot

By consistently topping up a SIPP with a sound investment strategy, it’s possible to transform a small pension pot into…

Read more »

Buffett at the BRK AGM
Investing Articles

As stock markets rise, here’s what Warren Buffett’s doing

The market’s on a terrific run so far this year. But some forecasts predict stocks to take another tumble, and…

Read more »

Investing Articles

How to target a £60,000 second income with a brand-new investment portfolio

Zaven Boyrazian explains how to aim for a five-figure second income stream in the stock market with dividend shares when…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

Here are the latest price targets for Rivian and Tesla stock

Tesla stock's surged more than 30% over the past month, leading Rivian and peers higher. But what are the brokers…

Read more »

Investing Articles

How to grow an empty Stocks and Shares ISA to £100k

Zaven Boyrazian cuts through the fluff and breaks down the path to building a £100k Stocks and Shares ISA through…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

I’d spend £5k on these FTSE 100 shares to grow my money

The FTSE 100 includes many high-quality, global businesses. Our writer explores two of his favourites that could stand the test…

Read more »

Investing Articles

How to invest £500 a month in an ISA and aim for a passive income worth £70,000

Our writer believes there's never a better time to start investing for a passive income than today. This is how…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

2 mega-cheap growth stocks I think could surge in value!

These growth stocks have rocketed in value in recent weeks. Yet they remain dirt cheap and could be poised for…

Read more »